Since its founding in May 2014, shares of The EVEXIA Bio Fund have increased value from $100 to ~$220, with more than $180,000 AUM. The fund has generated and voted on 50+ pitches mostly centered on cutting-edge life science companies. Our partners have led exciting careers in healthcare, biotechnology, hedge funds, management consulting, and academic science.

Portfolio Management

All decisions are made by the partners whose votes total a majority of the votes present at EVEXIA meetings. Partners have the number of votes corresponding to the number of EVEXIA shares he or she owns. Any partner or member of the community may pitch an investment idea after submitting the pitch deck to the officers for approval.


New partners may be added quarterly. Partners are expected to attend and participate in meetings and contribute new investment ideas. Interested individuals may apply for membership by submitting a resume and cover letter to If approved by the officers, membership will voted upon at the following Quarterly Meeting. Once approved, new partners must invest in a minimum of 5 shares, submit the deposit slip, sign the Partnership Agreement, and submit a Schedule K-1 Tax form. Any partner may withdraw the partial or full value of his or her shares at the Annual Meeting in December, although special circumstances may be considered.

Investment Risks

Past performance does not necessarily predict future results. Investing in the life sciences involves considerable risk, including loss of capital. Individual partners are not liable for losses incurred by the EVEXIA Bio Fund.


EVEXIA Bio Fund regularly publishes our research, diligence, and investment theses as articles here on the EVEXIA website and on the crowd-sourced investing content platform Seeking Alpha in order to make our research and diligence more accessible to current and future members.

New Partner Forms

1140 investing 2019 ii8evv